These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 18401811)

  • 21. Characterizing the perception of the placebo effect in sports medicine.
    Brooling J; Pyne D; Fallon K; Fricker P
    Clin J Sport Med; 2008 Sep; 18(5):432-7. PubMed ID: 18806551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. World anti-doping regulations for 2005: essential changes for athletes and physicians.
    Pabinger C; Gruber G
    Arch Orthop Trauma Surg; 2006 May; 126(4):286-8. PubMed ID: 16333634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General practitioners knowledge, practice and training requirements in relation to doping in sport.
    Woods CB; Moynihan A
    Ir Med J; 2009 Jan; 102(1):8-10. PubMed ID: 19284009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities.
    Bojsen-Møller J; Christiansen AV
    Scand J Med Sci Sports; 2010 Dec; 20(6):861-7. PubMed ID: 19843266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The psychology behind doping in sport.
    Ehrnborg C; Rosén T
    Growth Horm IGF Res; 2009 Aug; 19(4):285-7. PubMed ID: 19477668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accidental breaches of the doping regulations in sport: is there a need to improve the education of sportspeople?
    Somerville SJ; Lewis M; Kuipers H
    Br J Sports Med; 2005 Aug; 39(8):512-6; discussion 516. PubMed ID: 16046333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Illicit drugs and cardiac arrhythmias in athletes.
    Furlanello F; Serdoz LV; Cappato R; De Ambroggi L
    Eur J Cardiovasc Prev Rehabil; 2007 Aug; 14(4):487-94. PubMed ID: 17667636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug use in English professional football.
    Waddington I; Malcolm D; Roderick M; Naik R
    Br J Sports Med; 2005 Apr; 39(4):e18; discussion e18. PubMed ID: 15793076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene doping.
    Haisma HJ; de Hon O
    Int J Sports Med; 2006 Apr; 27(4):257-66. PubMed ID: 16572366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of performance level on dietary supplementation in elite Canadian athletes.
    Erdman KA; Fung TS; Reimer RA
    Med Sci Sports Exerc; 2006 Feb; 38(2):349-56. PubMed ID: 16531906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical therapists' knowledge, advice, and administration of nonprescription medications to their clients.
    Lansbury G; Sullivan G
    J Allied Health; 2002; 31(1):43-50. PubMed ID: 11905394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doping in sports: knowledge and attitudes among parents of Austrian junior athletes.
    Blank C; Leichtfried V; Schaiter R; Fürhapter C; Müller D; Schobersberger W
    Scand J Med Sci Sports; 2015 Feb; 25(1):116-24. PubMed ID: 24372621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elite athletes' attitudes towards the use of placebo-induced performance enhancement in sports.
    Bérdi M; Köteles F; Hevesi K; Bárdos G; Szabo A
    Eur J Sport Sci; 2015; 15(4):315-21. PubMed ID: 25189187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W; Delbeke FT
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Over-the-counter medication use in preschool children.
    Ecklund CR; Ross MC
    J Pediatr Health Care; 2001; 15(4):168-72. PubMed ID: 11462123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Societal perspectives on over-the-counter (OTC) medicines.
    Wazaify M; Shields E; Hughes CM; McElnay JC
    Fam Pract; 2005 Apr; 22(2):170-6. PubMed ID: 15710640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication use by athletes at the Athens 2004 Summer Olympic Games.
    Tsitsimpikou C; Tsiokanos A; Tsarouhas K; Schamasch P; Fitch KD; Valasiadis D; Jamurtas A
    Clin J Sport Med; 2009 Jan; 19(1):33-8. PubMed ID: 19124981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doping and supplementation: the attitudes of talented young athletes.
    Bloodworth AJ; Petróczi A; Bailey R; Pearce G; McNamee MJ
    Scand J Med Sci Sports; 2012 Apr; 22(2):293-301. PubMed ID: 20973831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving athletes' perspectives of sport psychology consultation: a controlled evaluation of two interview methods.
    Donohue B; Dickens Y; Lancer K; Covassin T; Hash A; Miller A; Genet J
    Behav Modif; 2004 Mar; 28(2):182-93. PubMed ID: 14997947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.